IGKV1D-22 and systemic lupus erythematosus: These findings suggest distinct roles for these analytes in contributing to CI in SLE patients, with IL-6 and TNF-α affecting specific pathways (e.g. front cortical) (47) and S100A8/A9 exerting a more widespread neuroinflammatory effect, impacting multiple brain regions simultaneously (45, 46).